Evidence map›Paper›PMID 40569898›Full record

ArticleJournal of the International AIDS Society2025

Poor post-exposure prophylaxis completion despite improvements in post-violence service delivery in 14 PEPFAR-supported sub-Saharan African countries, 2018-2023.

Udhayashankar Kanagasabai, Stephanie M Davis, Viva Thorsen, Emily Rowlinson, Anne Laterra, Jennifer Hegle, Carrine Angumua, Alexandre Ekra, Minlangu Mpingulu, Meklit Getahun and 14 more

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. HIV Post Exposure Prophylaxis: prospects, opportunities and challenges.Journal of the International AIDS Society · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Udhayashankar Kanagasabai *HIV Prevention Branch, Division of Global HIV and Tuberculosis, CDC, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0003-1694-9344
Stephanie M DavisHIV Prevention Branch, Division of Global HIV and Tuberculosis, CDC, Atlanta, Georgia, USA.
Viva Thorsen *HIV Prevention Branch, Division of Global HIV and Tuberculosis, CDC, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-4654-6530
Emily RowlinsonHIV Prevention Branch, Division of Global HIV and Tuberculosis, CDC, Atlanta, Georgia, USA.
Anne LaterraHIV Prevention Branch, Division of Global HIV and Tuberculosis, CDC, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0001-7277-3350
Jennifer HegleHIV Prevention Branch, Division of Global HIV and Tuberculosis, CDC, Atlanta, Georgia, USA.
Carrine AngumuaDivision of Global HIV and Tuberculosis, CDC, Yaounde, Cameroon.
Alexandre EkraDivision of Global HIV and Tuberculosis, CDC, Abidjan, Cote d'Ivoire.
Minlangu MpinguluDivision of Global HIV and Tuberculosis, CDC, Kinshasa, Democratic Republic of the Congo.
Meklit GetahunDivision of Global HIV and Tuberculosis, CDC, Addis Ababa, Ethiopia.ORCID https://orcid.org/0009-0003-2213-0906
Fikirte SidaDivision of Global HIV and Tuberculosis, CDC, Addis Ababa, Ethiopia.
Phumzile MndzebeleDivision of Global HIV and Tuberculosis, CDC, Mbabane, Eswatini.
Caroline KambonaDivision of Global HIV and Tuberculosis, CDC, Nairobi, Kenya.
Puleng RamphallaDivision of Global HIV and Tuberculosis, CDC, Maseru, Lesotho.
Eunice MtingwiDivision of Global HIV and Tuberculosis, CDC, Lilongwe, Malawi.
Wezi MsungamaDivision of Global HIV and Tuberculosis, CDC, Lilongwe, Malawi.
Meghan DuffyDivision of Global HIV and Tuberculosis, CDC, Maputo, Mozambique.ORCID https://orcid.org/0000-0003-0786-8964
Bukola AdewumiDivision of Global HIV and Tuberculosis, CDC, Abuja, Nigeria.
Ezeomu OlotuDivision of Global HIV and Tuberculosis, CDC, Abuja, Nigeria.ORCID https://orcid.org/0000-0002-4936-9314
Jackson SebezaDivision of Global HIV and Tuberculosis, CDC, Kigali, Rwanda.
Jane KitalileDivision of Global HIV and Tuberculosis, CDC, Dar es Salam, Tanzania.
Rose ApondiDivision of Global HIV and Tuberculosis, CDC, Kampala, Uganda.
Carlos MuleyaDivision of Global HIV and Tuberculosis, CDC, Lusaka, Zambia.
Meagan CainHIV Prevention Branch, Division of Global HIV and Tuberculosis, CDC, Atlanta, Georgia, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSexual violence (SV) affects millions globally and has a well-documented bidirectional association with HIV. Post-exposure prophylaxis (PEP) is a critical, yet often underutilized, HIV prevention tool in post-SV care. Despite its potential impact to reduce HIV transmission, SV care remains an overlooked service delivery point for HIV prevention. The U.S. Centers for Disease Control and Prevention (CDC), as part of the President's Emergency Plan for AIDS Relief (PEPFAR), supports PEP provision within broader post-violence care (PVC) services. Understanding PEP utilization is crucial for optimizing service delivery and HIV prevention efforts.

methodsUsing Monitoring Evaluation and Reporting data from fiscal years 2018-2023, we conducted a descriptive analysis of clients who received PVC and SV services through CDC-supported programming in 14 sub-Saharan African countries.

resultsFrom 2018 to 2023, the annual number of clients receiving any PVC, and specifically SV, services increased by 233% (in 2018, n = 206,764; in 2023, n = 689,349) and 163% (in 2018, n = 42,848; in 2023, n = 112,838), respectively. Fewer than half of SV clients completed PEP (38% in 2018, n = 16,103; 31% in 2023, n = 35,118). Across all years combined, most SV clients (female: 185,414; male: 59,618) were aged 15-19 years. The age band and sex with the lowest proportion of clients completing PEP were males aged 15-19 (4%, n = 2296).

conclusionsThe findings underscore a critical gap between the scaling of SV services and the completion of PEP within violence response programmes. Innovative implementation science approaches may help to identify and address barriers inhibiting effective PEP delivery and uptake within PVC service delivery programmes. Enhancing PEP uptake and completion can support mitigating the bidirectional relationship between violence and HIV acquisition, particularly among vulnerable populations like adolescents and young adults. Low PEP coverage also reflects missed opportunities, particularly among adolescent girls and young women, who experience disproportionate rates of HIV acquisition.

Indexed as

HIV InfectionsPost-Exposure ProphylaxisSex OffensesAdolescentAdultAfrica South of the SaharaFemaleHumansMaleMiddle AgedYoung AdultAfricaHIVHIV preventionintimate partner violencepost‐exposure prophylaxissexual violence

Identifiers

PMID40569898
PMCPMC12231646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.